
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+1
PYC Therapeutics (ASX: PYC) is a clinical stage biotechnology company pioneering a new generation of RNA therapeutics for genetic diseases. It works by combining two complementary platforms: RNA-based drug design and PYCs proprietary drug delivery technology. PYCs library of naturally derived cell penetrating peptides provide its delivery platform to overcome the major challenges of RNA therapeutics - getting into the target cell. PYC believes its PPMO (Peptide conjugated Phosphorodiamidate Morpholino Oligomer) technology enables a safer and more effective RNA therapeutic to address the underlying drivers of a range of genetic diseases for which no treatment solutions exist today. The Company...
Rna,retinal disease,rare disease,cell-penetrating peptides,retinitis pigmentosa,and neurodegenerative disease
Pyc therapeutics (asx: pyc) operates in the Biotechnology industry.
Pyc therapeutics (asx: pyc)'s revenue is 11m - 100m
Pyc therapeutics (asx: pyc) has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.